Reassortant rotaviruses as potential live rotavirus vaccine candidates.
about
Phenotypic mixing during coinfection of cells with two strains of human rotavirusHumoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus.Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellations.RNA-binding and capping activities of proteins in rotavirus open coresSerotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections.Multimers formed by the rotavirus nonstructural protein NSP2 bind to RNA and have nucleoside triphosphatase activity.Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin.De novo synthesis of minus strand RNA by the rotavirus RNA polymerase in a cell-free system involves a novel mechanism of initiation.A base-specific recognition signal in the 5' consensus sequence of rotavirus plus-strand RNAs promotes replication of the double-stranded RNA genome segmentsRotavirus infection of cells in culture induces activation of RhoA and changes in the actin and tubulin cytoskeletonDissecting rotavirus particle-raft interaction with small interfering RNAs: insights into rotavirus transit through the secretory pathway.Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3.Effect of malnutrition on serum and milk antibodies in Zairian womenRotavirus vaccines: an overview.Eight-year survey of human rotavirus strains demonstrates circulation of unusual G and P types in HungaryThree-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstructionSerum rotavirus neutralizing-antibody titers compared by plaque reduction and enzyme-linked immunosorbent assay-based neutralization assaysHuman viral gastroenteritis.Selection of cold-adapted mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro.Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.Molecular basis of rotavirus virulence: role of gene segment 4.Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus.Diarrheal response of gnotobiotic pigs after fetal infection and neonatal challenge with homologous and heterologous human rotavirus strains.Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigenAcrylamide concentration affects the relative position of VP7 gene of serotype G2 strains as determined by polyacrylamide gel electrophoresisRotavirus gene structure and function.Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation techniqueRotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of lifeSerologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies.Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine.Analysis by plaque reduction neutralization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo.Analysis by RNA-RNA hybridization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo.Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates.Dot hybridization assay for distinction of rotavirus serotypes.Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4.Identification of serotype 9 human rotavirus by enzyme-linked immunosorbent assay with monoclonal antibodies.A longitudinal cohort study in calves evaluated for rotavirus infections from 1 to 12 months of age by sequential serological assays
P2860
Q27486879-021913E6-27FC-4A6C-9D90-A19818E0ED0DQ31160938-94C6A816-32A4-487A-8562-C09308983D6CQ33511956-898E8698-B0E7-4919-B4D1-F14E8FBC6B9FQ33641409-DF7E9F67-6DA2-4CBF-9296-E2FCDC7092F9Q33654939-2E2BBC8A-5624-42E8-9D73-E3028AE02F89Q33782483-B5AE7258-D228-40F5-8236-E6926F536B71Q33824798-A11D24C2-4D68-4137-B5E4-9F0F027EAC6FQ34335469-A91BFB09-5ADF-4C3A-BC86-849087D0B0B6Q34363088-0E61B228-377B-4FE3-A2E7-F2EE6B695696Q34366781-8940BC6A-49E6-4BA0-96AA-DED56BC77C4BQ34452168-A98E07F9-2C53-4A73-A5AF-9612ABAA82CAQ34545950-BCEF1EB4-9384-4E11-891C-59CC0D7069A1Q35123345-FB3D94D2-507C-4DB0-9A9E-3AAFF2C5EA83Q35225379-7733178B-E06A-45D5-AB94-93058D981CE9Q35371774-9F7A7F5C-719A-479E-A682-B3688197D6C6Q35551854-FA615850-B85E-4B9B-96DB-0DB0B4EFDB42Q36223160-F7367E21-4FE2-4400-AAD4-BD55286764E6Q36530963-36D6B6AF-8534-44D0-938D-9975D931EEAEQ36634738-AEF3A881-05C6-476C-B8E6-AB5D6F15D00AQ36637434-C8FA32BE-CB37-4997-9ED4-8A8AA026F138Q36637672-2848B784-FF8C-4E4D-9B5D-2EBBD9796377Q36795096-EAE71A37-0B2A-406C-B472-224743EE591EQ36855328-3C6C173F-7D44-493B-8E60-890E127A9EB3Q36866633-6BA9327E-1239-4C7B-B017-2EA797027041Q36871139-E86A1CB6-3F18-4C46-94B7-39362232D493Q36875550-6ED9CCDF-C277-4537-A5A7-D86A8EA2A74DQ36952509-42AA36BA-8FEA-4183-85E9-402DEC656EC4Q37055891-31AA64AC-9E53-43A7-93C0-E5BD3D4B7732Q37064328-D83065D3-79D3-489E-8A7B-E22F62D793B7Q37065953-3E3B5C7C-AC68-4F72-B21D-CDC8FC0DBF67Q37066056-11683853-6280-4B25-9224-4A64197A5D96Q37133579-B6E8C3A6-8418-41EC-B374-3F8187EDC4ABQ37135965-232125B8-C47F-492D-B4E5-FB76921C1FC2Q37135981-3D8CB30C-E981-4481-BC1D-2B6F03E1583AQ37164301-3D6F6EE1-ED29-45C2-90E1-EBE418AD8AD6Q37166956-A5FE56BA-319D-4C05-B6E1-4746CCC03602Q37169945-8BF6028C-2359-447F-AFBC-98158CABC493Q37171840-1857A830-89A2-4533-ADB2-742B940FF069Q37180510-B5720777-4E36-49B8-9C67-2304AADA2485Q37186138-37856ECD-5EB3-4820-B1AC-64683B883196
P2860
Reassortant rotaviruses as potential live rotavirus vaccine candidates.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Reassortant rotaviruses as potential live rotavirus vaccine candidates.
@en
type
label
Reassortant rotaviruses as potential live rotavirus vaccine candidates.
@en
prefLabel
Reassortant rotaviruses as potential live rotavirus vaccine candidates.
@en
P2093
P2860
P1433
P1476
Reassortant rotaviruses as potential live rotavirus vaccine candidates.
@en
P2093
Chanock RM
Greenberg HB
Kapikian AZ
P2860
P304
P407
P577
1985-03-01T00:00:00Z